Why BioNTech Stock Soared 46% in November

Shares of German clinical-stage biotech BioNTech (NASDAQ: BNTX) soared 45.5% in November, according to data from S&P Global Market Intelligence.

For context, the S&P 500 returned 11% last month.

Image source: Getty Images.